{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:28:56Z","timestamp":1791804536877,"version":"4.3.4"},"reference-count":212,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0519903"],"award-info":[{"award-number":["2024ZD0519903"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272751"],"award-info":[{"award-number":["82272751"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multidrug resistance (MDR) remains the principal impediment to curative oncology, driven by complex interplays between cancer cells and the tumor microenvironment (TME). While nanomedicines have sought to overcome these delivery barriers, their clinical translation is often hampered by the heterogeneity of the enhanced permeability and retention (EPR) effect and by inefficient intratumoral delivery. In this review, we argue that overcoming MDR requires a transition beyond traditional passive drug delivery, advocating active, localized remodeling of the tumor ecosystem. Next-generation injectable hydrogels are increasingly recognized as localized viscoelastic niches that combine controlled intratumoral retention with the capacity to actively modulate biological responses within tumor TME. By converging principles of mechanobiology and immunometabolism, these hydrogels enable a multi-tiered strategy to dismantle multidimensional MDR. This approach begins with the biomechanical softening of the extracellular matrix to decouple mechanotransduction driven by Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ), followed by the metabolic disruption of hypoxia-driven bioenergetics. Beyond the extracellular landscape, nanogel-enabled trafficking allows payloads to circumvent intracellular sequestration and efflux transporters, while immunomodulatory niches mobilize antitumor immunity through in situ vaccination and myeloid reprogramming. Finally, we evaluate the integration of artificial intelligence-driven design and patient-derived organoids as a technical bridge to reconcile laboratory ingenuity with clinical utility, aiming to transform the TME into a vulnerable therapeutic target.<\/jats:p>","DOI":"10.1186\/s12943-026-02660-3","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:53:03Z","timestamp":1775868783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Smart hydrogels for overcoming cancer multidrug resistance"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4985-3093","authenticated-orcid":false,"given":"Yong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zou-Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"issue":"3","key":"2660_CR1","first-page":"183","volume":"75","author":"KJ Pienta","year":"2025","unstructured":"Pienta KJ, Goodin PL, Amend SR. Defeating lethal cancer: Interrupting the ecologic and evolutionary basis of death from malignancy. CA Cancer J Clin. 2025;75(3):183\u2013202.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"2660_CR2","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1021\/acs.chemrev.0c00383","volume":"121","author":"RA Ward","year":"2021","unstructured":"Ward RA, et al. Challenges and Opportunities in Cancer Drug Resistance. Chem Rev. 2021;121(6):3297\u2013351.","journal-title":"Chem Rev"},{"key":"2660_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2014.11.002","volume":"18","author":"RJ Kathawala","year":"2015","unstructured":"Kathawala RJ, et al. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug Resist Updat. 2015;18:1\u201317.","journal-title":"Drug Resist Updat"},{"issue":"10","key":"2660_CR4","first-page":"869","volume":"67","author":"V Ling","year":"1983","unstructured":"Ling V, et al. Multidrug-resistance phenotype in Chinese hamster ovary cells. Cancer Treat Rep. 1983;67(10):869\u201374.","journal-title":"Cancer Treat Rep"},{"key":"2660_CR5","doi-asserted-by":"crossref","unstructured":"Ge M et al. Understanding and overcoming multidrug resistance in cancer. Nat Rev Clin Oncol, 2025.","DOI":"10.1038\/s41571-025-01059-1"},{"issue":"10","key":"2660_CR6","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, et al. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013;13(10):714\u201326.","journal-title":"Nat Rev Cancer"},{"issue":"7782","key":"2660_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan N, Baselga J, Hyman DM. A view on drug resistance in cancer. Nature. 2019;575(7782):299\u2013309.","journal-title":"Nature"},{"issue":"1","key":"2660_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002;2(1):48\u201358.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2660_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"1","key":"2660_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s43556-025-00352-w","volume":"6","author":"J Li","year":"2025","unstructured":"Li J, et al. Drug resistance in cancer: molecular mechanisms and emerging treatment strategies. Mol Biomed. 2025;6(1):111.","journal-title":"Mol Biomed"},{"issue":"5","key":"2660_CR11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541\u201350.","journal-title":"Nat Med"},{"issue":"11","key":"2660_CR12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41568-024-00745-z","volume":"24","author":"JA Linke","year":"2024","unstructured":"Linke JA, Munn LL, Jain RK. Compressive stresses in cancer: characterization and implications for tumour progression and treatment. Nat Rev Cancer. 2024;24(11):768\u201391.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"2660_CR13","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.trecan.2025.04.004","volume":"11","author":"AM Finger","year":"2025","unstructured":"Finger AM, et al. Tissue mechanics in tumor heterogeneity and aggression. Trends Cancer. 2025;11(8):806\u201324.","journal-title":"Trends Cancer"},{"issue":"7938","key":"2660_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","volume":"612","author":"R Xue","year":"2022","unstructured":"Xue R, et al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature. 2022;612(7938):141\u20137.","journal-title":"Nature"},{"key":"2660_CR15","doi-asserted-by":"crossref","unstructured":"Wang Y et al. Interplay between Matrix Viscoelasticity and Integrin Engagement Modulates Cancer-Associated Fibroblast States. Adv Healthc Mater, 2025: e00389.","DOI":"10.1002\/adhm.202500389"},{"issue":"11","key":"2660_CR16","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1021\/acs.molpharmaceut.5c00474","volume":"22","author":"X Yi","year":"2025","unstructured":"Yi X, et al. Drug Delivery Systems for Overcoming Physical Barriers in Cancer Therapy. Mol Pharm. 2025;22(11):6413\u201329.","journal-title":"Mol Pharm"},{"issue":"40","key":"2660_CR17","doi-asserted-by":"publisher","first-page":"e10004","DOI":"10.1002\/advs.202510004","volume":"12","author":"X Zhou","year":"2025","unstructured":"Zhou X, et al. Integrating Metabolic Modulation and Nanomedicine for Cancer Immunotherapy. Adv Sci (Weinh). 2025;12(40):e10004.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2660_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","volume":"23","author":"S Liu","year":"2024","unstructured":"Liu S, et al. Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. Mol Cancer. 2024;23(1):261.","journal-title":"Mol Cancer"},{"key":"2660_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cytogfr.2025.10.004","volume":"86","author":"R Malla","year":"2025","unstructured":"Malla R, Mangam C, Nagaraju GP. Pancreatic cancer exosomes: Their role in drug resistance and immunomodulation. Cytokine Growth Factor Rev. 2025;86:108\u201320.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"2660_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail M, Jiang CH, Li N. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduct Target Ther. 2025;10(1):227.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2660_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","volume":"8","author":"D Fan","year":"2023","unstructured":"Fan D, et al. Nanomedicine in cancer therapy. Signal Transduct Target Ther. 2023;8(1):293.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2660_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","volume":"17","author":"J Shi","year":"2017","unstructured":"Shi J, et al. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20\u201337.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"2660_CR23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nnano.2007.387","volume":"2","author":"D Peer","year":"2007","unstructured":"Peer D, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751\u201360.","journal-title":"Nat Nanotechnol"},{"issue":"12 Pt 1","key":"2660_CR24","first-page":"6387","volume":"46","author":"Y Matsumura","year":"1986","unstructured":"Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986;46(12 Pt 1):6387\u201392.","journal-title":"Cancer Res"},{"issue":"5","key":"2660_CR25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","volume":"19","author":"S Sindhwani","year":"2020","unstructured":"Sindhwani S, et al. The entry of nanoparticles into solid tumours. Nat Mater. 2020;19(5):566\u201375.","journal-title":"Nat Mater"},{"issue":"8","key":"2660_CR26","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1158\/0008-5472.CAN-12-4561","volume":"73","author":"U Prabhakar","year":"2013","unstructured":"Prabhakar U, et al. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res. 2013;73(8):2412\u20137.","journal-title":"Cancer Res"},{"issue":"5","key":"2660_CR27","doi-asserted-by":"publisher","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","volume":"1","author":"S Wilhelm","year":"2016","unstructured":"Wilhelm S, et al. Analysis of nanoparticle delivery to tumours. Nat Reviews Mater. 2016;1(5):16014.","journal-title":"Nat Reviews Mater"},{"key":"2660_CR28","doi-asserted-by":"publisher","first-page":"113991","DOI":"10.1016\/j.jconrel.2025.113991","volume":"385","author":"RM Pallares","year":"2025","unstructured":"Pallares RM, et al. Clinical cancer nanomedicines. J Control Release. 2025;385:113991.","journal-title":"J Control Release"},{"issue":"3","key":"2660_CR29","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1021\/acsnano.9b08142","volume":"14","author":"YH Cheng","year":"2020","unstructured":"Cheng YH, et al. Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach. ACS Nano. 2020;14(3):3075\u201395.","journal-title":"ACS Nano"},{"issue":"9","key":"2660_CR30","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","volume":"124","author":"MA Beach","year":"2024","unstructured":"Beach MA, et al. Polymeric Nanoparticles for Drug Delivery. Chem Rev. 2024;124(9):5505\u2013616.","journal-title":"Chem Rev"},{"key":"2660_CR31","doi-asserted-by":"publisher","first-page":"114614","DOI":"10.1016\/j.addr.2022.114614","volume":"191","author":"R Sun","year":"2022","unstructured":"Sun R, et al. The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives. Adv Drug Deliv Rev. 2022;191:114614.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"2660_CR32","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1080\/17425247.2024.2375400","volume":"21","author":"Y He","year":"2024","unstructured":"He Y, et al. Understanding nanoparticle-liver interactions in nanomedicine. Expert Opin Drug Deliv. 2024;21(6):829\u201343.","journal-title":"Expert Opin Drug Deliv"},{"key":"2660_CR33","doi-asserted-by":"crossref","unstructured":"Wu Q et al. Nanomedicine Reimagined: Translational Strategies for Precision Tumor Theranostics. Adv Mater, 2025: e10293.","DOI":"10.1002\/adma.202510293"},{"key":"2660_CR34","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.jconrel.2024.11.015","volume":"377","author":"DI Jeong","year":"2025","unstructured":"Jeong DI, et al. Cellulose nanocrystal-annealed hydrogel system for local chemo-metabolic therapy of melanoma. J Control Release. 2025;377:324\u201338.","journal-title":"J Control Release"},{"issue":"1","key":"2660_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jconrel.2011.11.031","volume":"159","author":"JB Wolinsky","year":"2012","unstructured":"Wolinsky JB, Colson YL, Grinstaff MW. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release. 2012;159(1):14\u201326.","journal-title":"J Control Release"},{"issue":"3","key":"2660_CR36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41577-022-00761-w","volume":"23","author":"H Du","year":"2023","unstructured":"Du H, et al. Tuning immunity through tissue mechanotransduction. Nat Rev Immunol. 2023;23(3):174\u201388.","journal-title":"Nat Rev Immunol"},{"key":"2660_CR37","doi-asserted-by":"crossref","unstructured":"Lanis MR, Kim S, Schneck JP. Hydrogels in the Immune Context: In Vivo Applications for Modulating Immune Responses in Cancer Therapy. Gels, 2025:11(11).","DOI":"10.3390\/gels11110889"},{"key":"2660_CR38","doi-asserted-by":"publisher","first-page":"tkaf025","DOI":"10.1093\/burnst\/tkaf025","volume":"13","author":"Y Wang","year":"2025","unstructured":"Wang Y, et al. Innovations in hydrogel therapies for diabetic wound healing: bridging the gap between pathophysiology and clinical application. Burns Trauma. 2025;13:tkaf025.","journal-title":"Burns Trauma"},{"issue":"47","key":"2660_CR39","doi-asserted-by":"publisher","first-page":"e12037","DOI":"10.1002\/advs.202512037","volume":"12","author":"G Xiang","year":"2025","unstructured":"Xiang G, et al. Programmable Hydrogels: Frontiers in Dynamic Closed-Loop Systems, Biomimetic Synergy, and Clinical Translation. Adv Sci (Weinh). 2025;12(47):e12037.","journal-title":"Adv Sci (Weinh)"},{"key":"2660_CR40","doi-asserted-by":"publisher","first-page":"102385","DOI":"10.1016\/j.mtbio.2025.102385","volume":"35","author":"X Deng","year":"2025","unstructured":"Deng X, Liu X, Zhao L. Multifunctional nanoplatforms for tumor microenvironment remodeling: Toward precision and intelligent cancer therapy. Mater Today Bio. 2025;35:102385.","journal-title":"Mater Today Bio"},{"key":"2660_CR41","first-page":"p0477","volume":"7","author":"Z Tang","year":"2024","unstructured":"Tang Z, et al. Intelligent Hydrogel-Assisted Hepatocellular Carcinoma Therapy. Res (Wash D C). 2024;7:p0477.","journal-title":"Res (Wash D C)"},{"issue":"3","key":"2660_CR42","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1021\/acsnano.2c11278","volume":"17","author":"Y Shou","year":"2023","unstructured":"Shou Y, et al. Dynamic Magneto-Softening of 3D Hydrogel Reverses Malignant Transformation of Cancer Cells and Enhances Drug Efficacy. ACS Nano. 2023;17(3):2851\u201367.","journal-title":"ACS Nano"},{"issue":"9","key":"2660_CR43","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/s41563-025-02234-6","volume":"24","author":"AR Sun","year":"2025","unstructured":"Sun AR, et al. Hybrid hydrogel-extracellular matrix scaffolds identify biochemical and mechanical signatures of cardiac ageing. Nat Mater. 2025;24(9):1489\u2013501.","journal-title":"Nat Mater"},{"key":"2660_CR44","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jcis.2025.01.146","volume":"685","author":"Y Chen","year":"2025","unstructured":"Chen Y, et al. An injectable nanocomposite hydrogel with deep penetration ability for enhanced photothermal and chemotherapy. J Colloid Interface Sci. 2025;685:268\u201379.","journal-title":"J Colloid Interface Sci"},{"issue":"35","key":"2660_CR45","doi-asserted-by":"publisher","first-page":"e2502969","DOI":"10.1002\/smll.202502969","volume":"21","author":"X Song","year":"2025","unstructured":"Song X, et al. AND Logic Gate Strategy for Targeted Melanoma Treatment Through Sequential Photosynthetic Oxygenation and Tyrosinase-Catalyzed Ferroptosis. Small. 2025;21(35):e2502969.","journal-title":"Small"},{"key":"2660_CR46","doi-asserted-by":"publisher","first-page":"121401","DOI":"10.1016\/j.biomaterials.2022.121401","volume":"282","author":"Z Yang","year":"2022","unstructured":"Yang Z, et al. Nano-oxygenated hydrogels for locally and permeably hypoxia relieving to heal chronic wounds. Biomaterials. 2022;282:121401.","journal-title":"Biomaterials"},{"key":"2660_CR47","doi-asserted-by":"publisher","first-page":"123568","DOI":"10.1016\/j.biomaterials.2025.123568","volume":"325","author":"Y Lu","year":"2026","unstructured":"Lu Y, et al. Chrono-controlled hydrogel platform orchestrates metabolic reprogramming and cuproptosis-driven immune activation against triple-negative breast cancer. Biomaterials. 2026;325:123568.","journal-title":"Biomaterials"},{"issue":"6","key":"2660_CR48","doi-asserted-by":"publisher","first-page":"e2303031","DOI":"10.1002\/adhm.202303031","volume":"13","author":"Y Chen","year":"2024","unstructured":"Chen Y, et al. Intratumoral Lactate Depletion Based on Injectable Nanoparticles-Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence. Adv Healthc Mater. 2024;13(6):e2303031.","journal-title":"Adv Healthc Mater"},{"key":"2660_CR49","first-page":"153","volume":"12","author":"J Shen","year":"2022","unstructured":"Shen J, et al. Exhausted local lactate accumulation via injectable nanozyme-functionalized hydrogel microsphere for inflammation relief and tissue regeneration. Bioact Mater. 2022;12:153\u201368.","journal-title":"Bioact Mater"},{"issue":"11","key":"2660_CR50","doi-asserted-by":"publisher","first-page":"13509","DOI":"10.1021\/acsami.3c17792","volume":"16","author":"Q Wang","year":"2024","unstructured":"Wang Q, et al. Elesclomol-Copper Nanoparticles Overcome Multidrug Resistance in Cancer Cells. ACS Appl Mater Interfaces. 2024;16(11):13509\u201324.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"10\u201311","key":"2660_CR51","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s12272-024-01514-0","volume":"47","author":"YL Lo","year":"2024","unstructured":"Lo YL, et al. Modulating versatile pathways using a cleavable PEG shell and EGFR-targeted nanoparticles to deliver CRISPR-Cas9 and docetaxel for triple-negative breast cancer inhibition. Arch Pharm Res. 2024;47(10\u201311):829\u201353.","journal-title":"Arch Pharm Res"},{"key":"2660_CR52","doi-asserted-by":"publisher","first-page":"112638","DOI":"10.1016\/j.colsurfb.2022.112638","volume":"217","author":"HY Yang","year":"2022","unstructured":"Yang HY, et al. pH-responsive dynamically cross-linked nanogels with effective endo-lysosomal escape for synergetic cancer therapy based on intracellular co-delivery of photosensitizers and proteins. Colloids Surf B Biointerfaces. 2022;217:112638.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2660_CR53","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ijbiomac.2022.05.190","volume":"213","author":"M Arjama","year":"2022","unstructured":"Arjama M, Mehnath S, Jeyaraj M. Self-assembled hydrogel nanocube for stimuli responsive drug delivery and tumor ablation by phototherapy against breast cancer. Int J Biol Macromol. 2022;213:435\u201346.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"2660_CR54","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1021\/acs.biomac.5c00051","volume":"26","author":"F Du","year":"2025","unstructured":"Du F, et al. Fe-Doped Carbon Dots-Incorporated In Situ Hydrogel for Near Infrared-Triggered Cascading Photothermal\/Thermodynamic Therapy to Boost Cancer Immunity Cycle. Biomacromolecules. 2025;26(4):2601\u201313.","journal-title":"Biomacromolecules"},{"issue":"23","key":"2660_CR55","doi-asserted-by":"publisher","first-page":"14877","DOI":"10.1021\/acsnano.3c08425","volume":"18","author":"Y Fu","year":"2024","unstructured":"Fu Y, et al. Syringeable Near-Infrared Light-Activated In Situ Immunogenic Hydrogel Boosts the Cancer-Immunity Cycle to Enhance Anticancer Immunity. ACS Nano. 2024;18(23):14877\u201392.","journal-title":"ACS Nano"},{"key":"2660_CR56","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jconrel.2024.06.052","volume":"372","author":"D Wang","year":"2024","unstructured":"Wang D, et al. Environmentally responsive hydrogel promotes vascular normalization to enhance STING anti-tumor immunity. J Control Release. 2024;372:403\u201316.","journal-title":"J Control Release"},{"issue":"11","key":"2660_CR57","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/s41551-020-0597-7","volume":"4","author":"F Wang","year":"2020","unstructured":"Wang F, et al. Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel. Nat Biomed Eng. 2020;4(11):1090\u2013101.","journal-title":"Nat Biomed Eng"},{"key":"2660_CR58","doi-asserted-by":"publisher","first-page":"1437071","DOI":"10.3389\/fphar.2024.1437071","volume":"15","author":"T Wang","year":"2024","unstructured":"Wang T, et al. Nanoparticles (NPs)-mediated lncMALAT1 silencing to reverse cisplatin resistance for effective hepatocellular carcinoma therapy. Front Pharmacol. 2024;15:1437071.","journal-title":"Front Pharmacol"},{"issue":"7350","key":"2660_CR59","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont S, et al. Role of YAP\/TAZ in mechanotransduction. Nature. 2011;474(7350):179\u201383.","journal-title":"Nature"},{"issue":"2","key":"2660_CR60","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1021\/acsnano.4c14874","volume":"19","author":"Z Li","year":"2025","unstructured":"Li Z, et al. MicroSphere 3D Structures Delay Tissue Senescence through Mechanotransduction. ACS Nano. 2025;19(2):2695\u2013714.","journal-title":"ACS Nano"},{"issue":"12","key":"2660_CR61","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nrm.2017.87","volume":"18","author":"T Panciera","year":"2017","unstructured":"Panciera T, et al. Mechanobiology of YAP and TAZ in physiology and disease. Nat Rev Mol Cell Biol. 2017;18(12):758\u201370.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2660_CR62","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41467-023-35856-y","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, et al. Niche stiffness sustains cancer stemness via TAZ and NANOG phase separation. Nat Commun. 2023;14(1):238.","journal-title":"Nat Commun"},{"issue":"12","key":"2660_CR63","doi-asserted-by":"publisher","first-page":"113996","DOI":"10.1016\/j.isci.2025.113996","volume":"28","author":"P Wu","year":"2025","unstructured":"Wu P, et al. High matrix stiffness triggers the YAP-OPA1-TET1\/3 loop to drive chemoresistance via enhanced nuclear-mitochondrial communication. iScience. 2025;28(12):113996.","journal-title":"iScience"},{"issue":"21","key":"2660_CR64","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1158\/0008-5472.CAN-23-0025","volume":"83","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, et al. Matrix Stiffness Triggers Lipid Metabolic Cross-talk between Tumor and Stromal Cells to Mediate Bevacizumab Resistance in Colorectal Cancer Liver Metastases. Cancer Res. 2023;83(21):3577\u201392.","journal-title":"Cancer Res"},{"issue":"2","key":"2660_CR65","doi-asserted-by":"publisher","first-page":"100023","DOI":"10.1016\/j.mbm.2023.100023","volume":"1","author":"T Li","year":"2023","unstructured":"Li T, et al. Extracellular cell matrix stiffness-driven drug resistance of breast cancer cells via EGFR activation. Mechanobiol Med. 2023;1(2):100023.","journal-title":"Mechanobiol Med"},{"issue":"10","key":"2660_CR66","doi-asserted-by":"publisher","first-page":"116372","DOI":"10.1016\/j.celrep.2025.116372","volume":"44","author":"P Biber","year":"2025","unstructured":"Biber P, et al. USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilization. Cell Rep. 2025;44(10):116372.","journal-title":"Cell Rep"},{"issue":"3","key":"2660_CR67","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nmat4489","volume":"15","author":"O Chaudhuri","year":"2016","unstructured":"Chaudhuri O, et al. Hydrogels with tunable stress relaxation regulate stem cell fate and activity. Nat Mater. 2016;15(3):326\u201334.","journal-title":"Nat Mater"},{"issue":"43","key":"2660_CR68","doi-asserted-by":"publisher","first-page":"e09672","DOI":"10.1002\/adma.202509672","volume":"37","author":"EA Hushka","year":"2025","unstructured":"Hushka EA, et al. Fully Synthetic Hydrogels Promote Robust Crypt Formation in Intestinal Organoids. Adv Mater. 2025;37(43):e09672.","journal-title":"Adv Mater"},{"issue":"18","key":"2660_CR69","doi-asserted-by":"publisher","first-page":"e2309562","DOI":"10.1002\/advs.202309562","volume":"11","author":"JJ Zhang","year":"2024","unstructured":"Zhang JJ, et al. Harnessing Mechanical Stress with Viscoelastic Biomaterials for Periodontal Ligament Regeneration. Adv Sci (Weinh). 2024;11(18):e2309562.","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"2660_CR70","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nmeth.3839","volume":"13","author":"SR Caliari","year":"2016","unstructured":"Caliari SR, Burdick JA. A practical guide to hydrogels for cell culture. Nat Methods. 2016;13(5):405\u201314.","journal-title":"Nat Methods"},{"key":"2660_CR71","doi-asserted-by":"crossref","unstructured":"Liang Y et al. Enzyme-Induced Matrix Softening Regulates Hepatocarcinoma Cancer Cell Phenotypes. Macromol Biosci, 2017: 17(9).","DOI":"10.1002\/mabi.201700117"},{"issue":"12","key":"2660_CR72","doi-asserted-by":"publisher","first-page":"101588","DOI":"10.1016\/j.jhepr.2025.101588","volume":"7","author":"K Wu","year":"2025","unstructured":"Wu K, et al. Tumor peripheral stiffness modulates lenvatinib resistance in HCC preclinical models by regulating FIS1-dependent mitophagy. JHEP Rep. 2025;7(12):101588.","journal-title":"JHEP Rep"},{"issue":"7","key":"2660_CR73","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1039\/D0BM02194F","volume":"9","author":"P Yuan","year":"2021","unstructured":"Yuan P, et al. A sandwich cell culture platform with NIR-responsive dynamic stiffness to modulate macrophage phenotypes. Biomater Sci. 2021;9(7):2553\u201361.","journal-title":"Biomater Sci"},{"issue":"7822","key":"2660_CR74","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41586-020-2612-2","volume":"584","author":"O Chaudhuri","year":"2020","unstructured":"Chaudhuri O, et al. Effects of extracellular matrix viscoelasticity on cellular behaviour. Nature. 2020;584(7822):535\u201346.","journal-title":"Nature"},{"issue":"5","key":"2660_CR75","doi-asserted-by":"publisher","first-page":"e2410802","DOI":"10.1002\/adma.202410802","volume":"37","author":"D Sun","year":"2025","unstructured":"Sun D, et al. Matrix Viscoelasticity Controls Differentiation of Human Blood Vessel Organoids into Arterioles and Promotes Neovascularization in Myocardial Infarction. Adv Mater. 2025;37(5):e2410802.","journal-title":"Adv Mater"},{"issue":"50","key":"2660_CR76","doi-asserted-by":"publisher","first-page":"e2404885","DOI":"10.1002\/adma.202404885","volume":"36","author":"EM Carvalho","year":"2024","unstructured":"Carvalho EM, et al. Viscoelastic High-Molecular-Weight Hyaluronic Acid Hydrogels Support Rapid Glioblastoma Cell Invasion with Leader-Follower Dynamics. Adv Mater. 2024;36(50):e2404885.","journal-title":"Adv Mater"},{"issue":"2","key":"2660_CR77","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1021\/acs.biomac.4c01441","volume":"26","author":"H Nguyen","year":"2025","unstructured":"Nguyen H, et al. Fast-Relaxing Hydrogels Promote Pancreatic Adenocarcinoma Cell Aggressiveness through Integrin beta1 Signaling. Biomacromolecules. 2025;26(2):1098\u2013110.","journal-title":"Biomacromolecules"},{"issue":"3","key":"2660_CR78","doi-asserted-by":"publisher","first-page":"e2202009","DOI":"10.1002\/adhm.202202009","volume":"12","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, et al. Stress Relaxation-Induced Colon Tumor Multicellular Spheroid Culture Based on Biomimetic Hydrogel for Nanoenzyme Ferroptosis Sensitization Evaluation. Adv Healthc Mater. 2023;12(3):e2202009.","journal-title":"Adv Healthc Mater"},{"issue":"8","key":"2660_CR79","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41563-022-01293-3","volume":"21","author":"KH Vining","year":"2022","unstructured":"Vining KH, et al. Mechanical checkpoint regulates monocyte differentiation in fibrotic niches. Nat Mater. 2022;21(8):939\u201350.","journal-title":"Nat Mater"},{"issue":"38","key":"2660_CR80","doi-asserted-by":"publisher","first-page":"15101","DOI":"10.1073\/pnas.1213353109","volume":"109","author":"T Stylianopoulos","year":"2012","unstructured":"Stylianopoulos T, et al. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc Natl Acad Sci U S A. 2012;109(38):15101\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"27","key":"2660_CR81","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1200\/JCO.20.00590","volume":"38","author":"E Van Cutsem","year":"2020","unstructured":"Van Cutsem E, et al. Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma. J Clin Oncol. 2020;38(27):3185\u201394.","journal-title":"J Clin Oncol"},{"key":"2660_CR82","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.actbio.2019.06.033","volume":"96","author":"D Wu","year":"2019","unstructured":"Wu D, et al. An injectable and tumor-specific responsive hydrogel with tissue-adhesive and nanomedicine-releasing abilities for precise locoregional chemotherapy. Acta Biomater. 2019;96:123\u201336.","journal-title":"Acta Biomater"},{"issue":"4","key":"2660_CR83","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1021\/acsptsci.3c00304","volume":"7","author":"S Yu","year":"2024","unstructured":"Yu S, et al. Polydopamine-Based Resveratrol-Hyaluronidase Nanomedicine Inhibited Pancreatic Cancer Cell Invasive Phenotype in Hyaluronic Acid Enrichment Tumor Sphere Model. ACS Pharmacol Transl Sci. 2024;7(4):1013\u201322.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"6","key":"2660_CR84","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","volume":"25","author":"AD Rhim","year":"2014","unstructured":"Rhim AD, et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25(6):735\u201347.","journal-title":"Cancer Cell"},{"issue":"10","key":"2660_CR85","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41568-024-00736-0","volume":"24","author":"S Guelfi","year":"2024","unstructured":"Guelfi S, Hodivala-Dilke K, Bergers G. Targeting the tumour vasculature: from vessel destruction to promotion. Nat Rev Cancer. 2024;24(10):655\u201375.","journal-title":"Nat Rev Cancer"},{"issue":"49","key":"2660_CR86","doi-asserted-by":"publisher","first-page":"e1801964","DOI":"10.1002\/adma.201801964","volume":"30","author":"L Yu","year":"2018","unstructured":"Yu L, Hu P, Chen Y. Material Chemistry, Multifunctionality, and Gas Therapy. Adv Mater. 2018;30(49):e1801964.","journal-title":"Adv Mater"},{"issue":"14","key":"2660_CR87","doi-asserted-by":"publisher","first-page":"e2307143","DOI":"10.1002\/advs.202307143","volume":"11","author":"W Wang","year":"2024","unstructured":"Wang W, et al. A NRF2 Regulated and the Immunosuppressive Microenvironment Reversed Nanoplatform for Cholangiocarcinoma Photodynamic-Gas Therapy. Adv Sci (Weinh). 2024;11(14):e2307143.","journal-title":"Adv Sci (Weinh)"},{"issue":"37","key":"2660_CR88","doi-asserted-by":"publisher","first-page":"e2202625","DOI":"10.1002\/adma.202202625","volume":"34","author":"C Yang","year":"2022","unstructured":"Yang C, et al. Supramolecular Nitric Oxide Depot for Hypoxic Tumor Vessel Normalization and Radiosensitization. Adv Mater. 2022;34(37):e2202625.","journal-title":"Adv Mater"},{"issue":"3","key":"2660_CR89","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","volume":"14","author":"M Liao","year":"2024","unstructured":"Liao M, et al. Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer. Acta Pharm Sin B. 2024;14(3):953\u20131008.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"2660_CR90","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40164-025-00622-x","volume":"14","author":"M Lv","year":"2025","unstructured":"Lv M, et al. Lactylation modification in cancer: mechanisms, functions, and therapeutic strategies. Exp Hematol Oncol. 2025;14(1):32.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"2660_CR91","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen J, et al. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10(1):38.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"2660_CR92","doi-asserted-by":"publisher","first-page":"189162","DOI":"10.1016\/j.bbcan.2024.189162","volume":"1879","author":"K Kang","year":"2024","unstructured":"Kang K, et al. T cell exhaustion in human cancers. Biochim Biophys Acta Rev Cancer. 2024;1879(5):189162.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"8","key":"2660_CR93","doi-asserted-by":"publisher","first-page":"e2104671","DOI":"10.1002\/advs.202104671","volume":"9","author":"X Li","year":"2022","unstructured":"Li X, et al. A Valve-Closing Starvation Strategy for Amplification of Tumor-Specific Chemotherapy. Adv Sci (Weinh). 2022;9(8):e2104671.","journal-title":"Adv Sci (Weinh)"},{"issue":"10","key":"2660_CR94","doi-asserted-by":"publisher","first-page":"e2308229","DOI":"10.1002\/advs.202308229","volume":"11","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, et al. Adjuvant Hydrogel-Optimized Enzymatic Cascade Reaction for Tumor Chemodynamic-Immunotherapy. Adv Sci (Weinh). 2024;11(10):e2308229.","journal-title":"Adv Sci (Weinh)"},{"key":"2660_CR95","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.actbio.2022.09.024","volume":"153","author":"R Xu","year":"2022","unstructured":"Xu R, et al. A multifunctional cascade bioreactor based on a layered double oxides composite hydrogel for synergetic tumor chemodynamic\/starvation\/photothermal therapy. Acta Biomater. 2022;153:494\u2013504.","journal-title":"Acta Biomater"},{"issue":"Pt 3","key":"2660_CR96","doi-asserted-by":"publisher","first-page":"136444","DOI":"10.1016\/j.ijbiomac.2024.136444","volume":"281","author":"S Agrawal","year":"2024","unstructured":"Agrawal S, Singh GK, Tiwari S. Focused starvation of tumor cells using glucose oxidase: A comprehensive review. Int J Biol Macromol. 2024;281(Pt 3):136444.","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"2660_CR97","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1158\/0008-5472.CAN-12-2796","volume":"73","author":"V Estrella","year":"2013","unstructured":"Estrella V, et al. Acidity generated by the tumor microenvironment drives local invasion. Cancer Res. 2013;73(5):1524\u201335.","journal-title":"Cancer Res"},{"issue":"7546","key":"2660_CR98","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nature14362","volume":"520","author":"S Schoors","year":"2015","unstructured":"Schoors S, et al. Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature. 2015;520(7546):192\u20137.","journal-title":"Nature"},{"issue":"12","key":"2660_CR99","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/s41388-017-0070-6","volume":"37","author":"MX Liu","year":"2018","unstructured":"Liu MX, et al. Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma. Oncogene. 2018;37(12):1637\u201353.","journal-title":"Oncogene"},{"issue":"1","key":"2660_CR100","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41574-018-0096-z","volume":"15","author":"FJ Gonzalez","year":"2018","unstructured":"Gonzalez FJ, Xie C, Jiang C. The role of hypoxia-inducible factors in metabolic diseases. Nat Rev Endocrinol. 2018;15(1):21\u201332.","journal-title":"Nat Rev Endocrinol"},{"issue":"16","key":"2660_CR101","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1158\/0008-5472.CAN-13-0661","volume":"73","author":"H Fang","year":"2013","unstructured":"Fang H, Declerck YA. Targeting the tumor microenvironment: from understanding pathways to effective clinical trials. Cancer Res. 2013;73(16):4965\u201377.","journal-title":"Cancer Res"},{"issue":"1","key":"2660_CR102","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-022-01313-4","volume":"15","author":"P Jin","year":"2022","unstructured":"Jin P, et al. Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. J Hematol Oncol. 2022;15(1):97.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"2660_CR103","doi-asserted-by":"publisher","first-page":"e1805798","DOI":"10.1002\/adma.201805798","volume":"32","author":"J Gao","year":"2020","unstructured":"Gao J, Zhan J, Yang Z. Enzyme-Instructed Self-Assembly (EISA) and Hydrogelation of Peptides. Adv Mater. 2020;32(3):e1805798.","journal-title":"Adv Mater"},{"key":"2660_CR104","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.actbio.2022.11.008","volume":"155","author":"C Wu","year":"2023","unstructured":"Wu C, et al. Nanofibrillar peptide hydrogels for self-delivery of lonidamine and synergistic photodynamic therapy. Acta Biomater. 2023;155:139\u201353.","journal-title":"Acta Biomater"},{"key":"2660_CR105","doi-asserted-by":"publisher","first-page":"123391","DOI":"10.1016\/j.biomaterials.2025.123391","volume":"322","author":"X Yao","year":"2025","unstructured":"Yao X, et al. Radiation-triggerable bioreactors enable bioenergetic reprograming of cancer stem cell plasticity via targeted arginine metabolism disruption for augmented radio-immunotherapy. Biomaterials. 2025;322:123391.","journal-title":"Biomaterials"},{"issue":"22","key":"2660_CR106","doi-asserted-by":"publisher","first-page":"7856","DOI":"10.1039\/D0CS00379D","volume":"49","author":"J Han","year":"2020","unstructured":"Han J, et al. Cancer stem cell-targeted bio-imaging and chemotherapeutic perspective. Chem Soc Rev. 2020;49(22):7856\u201378.","journal-title":"Chem Soc Rev"},{"key":"2660_CR107","doi-asserted-by":"publisher","first-page":"115218","DOI":"10.1016\/j.colsurfb.2025.115218","volume":"258","author":"W Yao","year":"2026","unstructured":"Yao W, et al. Biocompatible hydrogel co-delivering salvigenin and iridium (III) complex overcomes cancer stemness and cisplatin resistance in esophageal squamous cell carcinoma. Colloids Surf B Biointerfaces. 2026;258:115218.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2660_CR108","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.semcancer.2023.09.002","volume":"96","author":"GL Semenza","year":"2023","unstructured":"Semenza GL. Targeting intratumoral hypoxia to enhance anti-tumor immunity. Semin Cancer Biol. 2023;96:5\u201310.","journal-title":"Semin Cancer Biol"},{"issue":"33","key":"2660_CR109","doi-asserted-by":"publisher","first-page":"7129","DOI":"10.1002\/adma.201601902","volume":"28","author":"Q Chen","year":"2016","unstructured":"Chen Q, et al. Intelligent Albumin-MnO2 Nanoparticles as pH-\/H2 O2 -Responsive Dissociable Nanocarriers to Modulate Tumor Hypoxia for Effective Combination Therapy. Adv Mater. 2016;28(33):7129\u201336.","journal-title":"Adv Mater"},{"issue":"4\u20136","key":"2660_CR110","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1089\/ars.2023.0445","volume":"41","author":"J Li","year":"2024","unstructured":"Li J, et al. Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies. Antioxid Redox Signal. 2024;41(4\u20136):322\u201341.","journal-title":"Antioxid Redox Signal"},{"key":"2660_CR111","first-page":"112","volume":"7","author":"NK Pandey","year":"2022","unstructured":"Pandey NK, et al. Aggregation-induced emission luminogens for highly effective microwave dynamic therapy. Bioact Mater. 2022;7:112\u201325.","journal-title":"Bioact Mater"},{"key":"2660_CR112","doi-asserted-by":"crossref","unstructured":"Wicks EE, Semenza GL. Hypoxia-inducible factors: cancer progression and clinical translation. J Clin Invest, 2022; 132(11).","DOI":"10.1172\/JCI159839"},{"key":"2660_CR113","doi-asserted-by":"publisher","first-page":"119578","DOI":"10.1016\/j.biomaterials.2019.119578","volume":"228","author":"A Sahu","year":"2020","unstructured":"Sahu A, Kwon I, Tae G. Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia. Biomaterials. 2020;228:119578.","journal-title":"Biomaterials"},{"issue":"1076","key":"2660_CR114","doi-asserted-by":"publisher","first-page":"20160939","DOI":"10.1259\/bjr.20160939","volume":"90","author":"DR Grimes","year":"2017","unstructured":"Grimes DR, Warren DR, Warren S. Hypoxia imaging and radiotherapy: bridging the resolution gap. Br J Radiol. 2017;90(1076):20160939.","journal-title":"Br J Radiol"},{"issue":"2","key":"2660_CR115","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/ars.2013.5759","volume":"21","author":"CT Lee","year":"2014","unstructured":"Lee CT, Boss MK, Dewhirst MW. Imaging tumor hypoxia to advance radiation oncology. Antioxid Redox Signal. 2014;21(2):313\u201337.","journal-title":"Antioxid Redox Signal"},{"issue":"24","key":"2660_CR116","doi-asserted-by":"publisher","first-page":"27551","DOI":"10.1021\/acsami.2c02949","volume":"14","author":"M Zhang","year":"2022","unstructured":"Zhang M, et al. Oxygen-Generating Hydrogels Overcome Tumor Hypoxia to Enhance Photodynamic\/Gas Synergistic Therapy. ACS Appl Mater Interfaces. 2022;14(24):27551\u201363.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2660_CR117","doi-asserted-by":"publisher","first-page":"122620","DOI":"10.1016\/j.biomaterials.2024.122620","volume":"309","author":"H Zhao","year":"2024","unstructured":"Zhao H, et al. Energy-storing DNA-based hydrogel remodels tumor microenvironments for laser-free photodynamic immunotherapy. Biomaterials. 2024;309:122620.","journal-title":"Biomaterials"},{"key":"2660_CR118","doi-asserted-by":"publisher","first-page":"102407","DOI":"10.1016\/j.cis.2021.102407","volume":"294","author":"MP Krafft","year":"2021","unstructured":"Krafft MP, Riess JG. Therapeutic oxygen delivery by perfluorocarbon-based colloids. Adv Colloid Interface Sci. 2021;294:102407.","journal-title":"Adv Colloid Interface Sci"},{"issue":"2","key":"2660_CR119","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1021\/jacs.3c12416","volume":"146","author":"X Chen","year":"2024","unstructured":"Chen X, Fluorinated A, et al. Zirconium Metal-Organic Framework for In Vivo Enhanced Photodynamic Therapy. J Am Chem Soc. 2024;146(2):1644\u201356.","journal-title":"J Am Chem Soc"},{"issue":"47","key":"2660_CR120","doi-asserted-by":"publisher","first-page":"43400","DOI":"10.1021\/jacs.5c10582","volume":"147","author":"W Jin","year":"2025","unstructured":"Jin W, et al. Biorthogonal PEGylation of Hierarchical Porous Metal-Organic Frameworks as Robust, Functional Nanocarriers for Hemoglobin-Based Oxygen Delivery. J Am Chem Soc. 2025;147(47):43400\u201314.","journal-title":"J Am Chem Soc"},{"issue":"6","key":"2660_CR121","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/btpr.56","volume":"24","author":"SI Gundersen","year":"2008","unstructured":"Gundersen SI, Palmer AF. Hemoglobin-based oxygen carrier enhanced tumor oxygenation: a novel strategy for cancer therapy. Biotechnol Prog. 2008;24(6):1353\u201364.","journal-title":"Biotechnol Prog"},{"key":"2660_CR122","doi-asserted-by":"publisher","first-page":"116713","DOI":"10.1016\/j.biopha.2024.116713","volume":"175","author":"HT Tsen","year":"2024","unstructured":"Tsen HT, et al. Cisplatin-activated and hemoglobin-mediated injectable hydrogel system for antitumor chemodynamic and chemotherapy. Biomed Pharmacother. 2024;175:116713.","journal-title":"Biomed Pharmacother"},{"issue":"14","key":"2660_CR123","doi-asserted-by":"publisher","first-page":"6042","DOI":"10.1021\/acs.nanolett.1c01220","volume":"21","author":"M Yuan","year":"2021","unstructured":"Yuan M, et al. A Robust Oxygen-Carrying Hemoglobin-Based Natural Sonosensitizer for Sonodynamic Cancer Therapy. Nano Lett. 2021;21(14):6042\u201350.","journal-title":"Nano Lett"},{"issue":"51","key":"2660_CR124","doi-asserted-by":"publisher","first-page":"56712","DOI":"10.1021\/acsami.0c15239","volume":"12","author":"Z Luo","year":"2020","unstructured":"Luo Z, et al. Injectable Porous Microchips with Oxygen Reservoirs and an Immune-Niche Enhance the Efficacy of CAR T Cell Therapy in Solid Tumors. ACS Appl Mater Interfaces. 2020;12(51):56712\u201322.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2660_CR125","doi-asserted-by":"publisher","first-page":"103470","DOI":"10.1016\/j.cis.2025.103470","volume":"340","author":"L Guo","year":"2025","unstructured":"Guo L, et al. Smart hydrogel: A new platform for cancer therapy. Adv Colloid Interface Sci. 2025;340:103470.","journal-title":"Adv Colloid Interface Sci"},{"key":"2660_CR126","doi-asserted-by":"publisher","first-page":"rbac069","DOI":"10.1093\/rb\/rbac069","volume":"9","author":"P Le Thi","year":"2022","unstructured":"Le Thi P, et al. Injectable reactive oxygen and nitrogen species-controlling hydrogels for tissue regeneration: current status and future perspectives. Regen Biomater. 2022;9:rbac069.","journal-title":"Regen Biomater"},{"issue":"3","key":"2660_CR127","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s40336-017-0231-1","volume":"5","author":"A Challapalli","year":"2017","unstructured":"Challapalli A, Carroll L, Aboagye EO. Molecular mechanisms of hypoxia in cancer. Clin Transl Imaging. 2017;5(3):225\u201353.","journal-title":"Clin Transl Imaging"},{"issue":"1","key":"2660_CR128","first-page":"29","volume":"13","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, et al. CaCO(3)-Assisted Preparation of pH-Responsive Immune-Modulating Nanoparticles for Augmented Chemo-Immunotherapy. Nanomicro Lett. 2020;13(1):29.","journal-title":"Nanomicro Lett"},{"issue":"4","key":"2660_CR129","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1021\/acs.accounts.6b00536","volume":"50","author":"N Oliva","year":"2017","unstructured":"Oliva N, et al. Designing Hydrogels for On-Demand Therapy. Acc Chem Res. 2017;50(4):669\u201379.","journal-title":"Acc Chem Res"},{"issue":"28","key":"2660_CR130","doi-asserted-by":"publisher","first-page":"e2207973","DOI":"10.1002\/smll.202207973","volume":"19","author":"G Lin","year":"2023","unstructured":"Lin G, et al. Smart Nanosystems for Overcoming Multiple Biological Barriers in Cancer Nanomedicines Transport: Design Principles, Progress, and Challenges. Small. 2023;19(28):e2207973.","journal-title":"Small"},{"key":"2660_CR131","doi-asserted-by":"crossref","unstructured":"Liu S, Sun M, Fan Z. Ultrasonic-Responsive Pluronic P105\/F127 Nanogels for Overcoming Multidrug Resistance in Cancer. Gels, 2025;11(11).","DOI":"10.3390\/gels11110878"},{"key":"2660_CR132","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.2147\/IJN.S497510","volume":"20","author":"Y Li","year":"2025","unstructured":"Li Y, et al. Overcoming Biological Barriers in Cancer Therapy: Cell Membrane-Based Nanocarrier Strategies for Precision Delivery. Int J Nanomed. 2025;20:3113\u201345.","journal-title":"Int J Nanomed"},{"issue":"14","key":"2660_CR133","doi-asserted-by":"publisher","first-page":"e2309355","DOI":"10.1002\/adma.202309355","volume":"36","author":"AM Lopez-Estevez","year":"2024","unstructured":"Lopez-Estevez AM, et al. Personalized Cancer Nanomedicine: Overcoming Biological Barriers for Intracellular Delivery of Biopharmaceuticals. Adv Mater. 2024;36(14):e2309355.","journal-title":"Adv Mater"},{"key":"2660_CR134","doi-asserted-by":"publisher","first-page":"100777","DOI":"10.1016\/j.drup.2021.100777","volume":"58","author":"Z Su","year":"2021","unstructured":"Su Z, et al. Novel nanomedicines to overcome cancer multidrug resistance. Drug Resist Updat. 2021;58:100777.","journal-title":"Drug Resist Updat"},{"key":"2660_CR135","doi-asserted-by":"crossref","unstructured":"Busa P et al. Conquering Cancer Multi-Drug Resistance Using Curcumin and Cisplatin Prodrug-Encapsulated Mesoporous Silica Nanoparticles for Synergistic Chemo- and Photodynamic Therapies. Nanomaterials (Basel), 2022;12(20).","DOI":"10.3390\/nano12203693"},{"issue":"3","key":"2660_CR136","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1021\/mp900191s","volume":"7","author":"EM Collnot","year":"2010","unstructured":"Collnot EM, et al. Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access. Mol Pharm. 2010;7(3):642\u201351.","journal-title":"Mol Pharm"},{"key":"2660_CR137","doi-asserted-by":"crossref","unstructured":"Arpa MD, Akbuga FJ. Chitosan-Based Nanogels in Modern Drug Delivery: Focus on Protein and Gene Applications. Gels, 2025; 11(9).","DOI":"10.3390\/gels11090735"},{"issue":"10","key":"2660_CR138","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman I, et al. The cancer-immunity cycle: Indication, genotype, and immunotype. Immunity. 2023;56(10):2188\u2013205.","journal-title":"Immunity"},{"key":"2660_CR139","doi-asserted-by":"publisher","first-page":"1535464","DOI":"10.3389\/fimmu.2025.1535464","volume":"16","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, et al. Current state of cancer immunity cycle: new strategies and challenges of using precision hydrogels to treat breast cancer. Front Immunol. 2025;16:1535464.","journal-title":"Front Immunol"},{"issue":"12","key":"2660_CR140","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41568-025-00872-1","volume":"25","author":"KB Kennel","year":"2025","unstructured":"Kennel KB, Greten FR. The immune microenvironment of colorectal cancer. Nat Rev Cancer. 2025;25(12):945\u201364.","journal-title":"Nat Rev Cancer"},{"issue":"26","key":"2660_CR141","doi-asserted-by":"publisher","first-page":"23629","DOI":"10.1021\/acsnano.5c01678","volume":"19","author":"T Wang","year":"2025","unstructured":"Wang T, et al. A Metal-Organic Framework-Based Immune-Regulating Nanocarrier Depot for Enhanced Combination Cancer Immunotherapy. ACS Nano. 2025;19(26):23629\u201346.","journal-title":"ACS Nano"},{"key":"2660_CR142","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.actbio.2024.04.025","volume":"180","author":"H Cui","year":"2024","unstructured":"Cui H, et al. Lymph node targeting strategy using a hydrogel sustained-release system to load effector memory T cells improves the anti-tumor efficacy of anti-PD-1. Acta Biomater. 2024;180:423\u201335.","journal-title":"Acta Biomater"},{"key":"2660_CR143","doi-asserted-by":"crossref","unstructured":"Zhou H et al. Spatiotemporally controlled delivery of biomacromolecules via injectable hydrogels for precision modulation of the tumor immune microenvironment. J Nanobiotechnol, 2025.","DOI":"10.1186\/s12951-025-03970-2"},{"key":"2660_CR144","doi-asserted-by":"publisher","first-page":"101277","DOI":"10.1016\/j.drup.2025.101277","volume":"83","author":"QQ Chai","year":"2025","unstructured":"Chai QQ, et al. Engineering nanoplatforms of bacterial outer membrane vesicles to overcome cancer therapy resistance. Drug Resist Updat. 2025;83:101277.","journal-title":"Drug Resist Updat"},{"key":"2660_CR145","doi-asserted-by":"publisher","first-page":"113927","DOI":"10.1016\/j.addr.2021.113927","volume":"177","author":"T Ye","year":"2021","unstructured":"Ye T, et al. Enhancing therapeutic performance of personalized cancer vaccine via delivery vectors. Adv Drug Deliv Rev. 2021;177:113927.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"2660_CR146","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1038\/s41467-023-39759-w","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, et al. Interventional hydrogel microsphere vaccine as an immune amplifier for activated antitumour immunity after ablation therapy. Nat Commun. 2023;14(1):4106.","journal-title":"Nat Commun"},{"issue":"1","key":"2660_CR147","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-025-01691-5","volume":"18","author":"M Shen","year":"2025","unstructured":"Shen M, et al. The cGAS\u2013STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications. J Hematol Oncol. 2025;18(1):40.","journal-title":"J Hematol Oncol"},{"issue":"11","key":"2660_CR148","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/cac2.70067","volume":"45","author":"Y Yan","year":"2025","unstructured":"Yan Y, et al. Breaking barriers: The cGAS-STING pathway as a novel frontier in cancer immunotherapy. Cancer Commun (Lond). 2025;45(11):1513\u201346.","journal-title":"Cancer Commun (Lond)"},{"issue":"10","key":"2660_CR149","first-page":"733","volume":"40","author":"R Shaik","year":"2025","unstructured":"Shaik R, et al. Advances in STING Pathway Modulation for Cancer and Immunotherapy: A Comprehensive Review of Preclinical and Clinical Studies (2020\u20132024). Cancer Biother Radiopharm. 2025;40(10):733\u201367.","journal-title":"Cancer Biother Radiopharm"},{"issue":"1","key":"2660_CR150","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40824-023-00343-4","volume":"27","author":"M Kim","year":"2023","unstructured":"Kim M, et al. Reprogramming the tumor microenvironment with biotechnology. Biomater Res. 2023;27(1):5.","journal-title":"Biomater Res"},{"key":"2660_CR151","doi-asserted-by":"publisher","first-page":"102258","DOI":"10.1016\/j.mtbio.2025.102258","volume":"34","author":"S Guo","year":"2025","unstructured":"Guo S, et al. Breaking the vicious cycle: Multifunctional nanomaterials targeting Tumor metabolic reprogramming to overcome T cell exhaustion and bone repair failure in bone tumors. Mater Today Bio. 2025;34:102258.","journal-title":"Mater Today Bio"},{"key":"2660_CR152","doi-asserted-by":"publisher","first-page":"1012927","DOI":"10.3389\/fimmu.2022.1012927","volume":"13","author":"Q Wei","year":"2022","unstructured":"Wei Q, et al. Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy. Front Immunol. 2022;13:1012927.","journal-title":"Front Immunol"},{"key":"2660_CR153","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jconrel.2024.03.028","volume":"369","author":"T Wu","year":"2024","unstructured":"Wu T, et al. Regulatory T cell-derived exosome mediated macrophages polarization for osteogenic differentiation in fracture repair. J Control Release. 2024;369:266\u201382.","journal-title":"J Control Release"},{"key":"2660_CR154","first-page":"139","volume":"58","author":"G Shi","year":"2026","unstructured":"Shi G, et al. Immunomodulatory supramolecular hydrogel for rheumatoid arthritis management via adenosine A2A receptor-mediated macrophage remodeling. Bioact Mater. 2026;58:139\u201356.","journal-title":"Bioact Mater"},{"issue":"4","key":"2660_CR155","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.trecan.2024.12.002","volume":"11","author":"J Hochstadt","year":"2025","unstructured":"Hochstadt J, Martinez Pacheco S, Casanova-Acebes M. Embracing diversity: macrophage complexity in cancer. Trends Cancer. 2025;11(4):351\u201364.","journal-title":"Trends Cancer"},{"issue":"1","key":"2660_CR156","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s41467-022-29388-0","volume":"13","author":"Z Li","year":"2022","unstructured":"Li Z, et al. Depletion of tumor associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment. Nat Commun. 2022;13(1):1845.","journal-title":"Nat Commun"},{"issue":"22","key":"2660_CR157","doi-asserted-by":"publisher","first-page":"e2001704","DOI":"10.1002\/smll.202001704","volume":"16","author":"Q Jiang","year":"2020","unstructured":"Jiang Q, et al. Platelet Membrane-Camouflaged Magnetic Nanoparticles for Ferroptosis-Enhanced Cancer Immunotherapy. Small. 2020;16(22):e2001704.","journal-title":"Small"},{"issue":"Pt 1","key":"2660_CR158","doi-asserted-by":"publisher","first-page":"114348","DOI":"10.1016\/j.jconrel.2025.114348","volume":"388","author":"K Li","year":"2025","unstructured":"Li K, et al. Enhancing cisplatin therapy for small cell lung cancer via a dual strategy of combining surufatinib and CD47 blockade. J Control Release. 2025;388(Pt 1):114348.","journal-title":"J Control Release"},{"issue":"1","key":"2660_CR159","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12951-025-03485-w","volume":"23","author":"H Liao","year":"2025","unstructured":"Liao H, et al. Sonodynamic therapy-boosted biomimetic nanoplatform targets ferroptosis and CD47 as vulnerabilities for cancer immunotherapy. J Nanobiotechnol. 2025;23(1):432.","journal-title":"J Nanobiotechnol"},{"issue":"11","key":"2660_CR160","doi-asserted-by":"publisher","first-page":"e2104619","DOI":"10.1002\/advs.202104619","volume":"9","author":"S Li","year":"2022","unstructured":"Li S, et al. Engineering ROS-Responsive Bioscaffolds for Disrupting Myeloid Cell-Driven Immunosuppressive Niche to Enhance PD-L1 Blockade-Based Postablative Immunotherapy. Adv Sci (Weinh). 2022;9(11):e2104619.","journal-title":"Adv Sci (Weinh)"},{"issue":"23","key":"2660_CR161","doi-asserted-by":"publisher","first-page":"e2310043","DOI":"10.1002\/adma.202310043","volume":"36","author":"NK Livingston","year":"2024","unstructured":"Livingston NK, et al. In Vivo Stimulation of Therapeutic Antigen-Specific T Cells in an Artificial Lymph Node Matrix. Adv Mater. 2024;36(23):e2310043.","journal-title":"Adv Mater"},{"key":"2660_CR162","doi-asserted-by":"publisher","first-page":"122420","DOI":"10.1016\/j.biomaterials.2023.122420","volume":"304","author":"B Liu","year":"2024","unstructured":"Liu B, et al. An engineered lymph node comprising porous collagen scaffold with hybridized biological signals embedded in B cell membrane coatings. Biomaterials. 2024;304:122420.","journal-title":"Biomaterials"},{"key":"2660_CR163","doi-asserted-by":"crossref","unstructured":"Cai Z et al. Implantable artificial lymph node enables rapid in vivo neoantigen-specific T-cell generation and expansion for improving antitumor immunity. J Immunother Cancer, 2025;13(12).","DOI":"10.1136\/jitc-2025-013043"},{"issue":"1","key":"2660_CR164","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","volume":"21","author":"SM Albelda","year":"2024","unstructured":"Albelda SM. CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn. Nat Rev Clin Oncol. 2024;21(1):47\u201366.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"2660_CR165","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41571-024-00903-0","volume":"21","author":"JN Brudno","year":"2024","unstructured":"Brudno JN, Kochenderfer JN. Current understanding and management of CAR T cell-associated toxicities. Nat Rev Clin Oncol. 2024;21(7):501\u201321.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2660_CR166","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-023-01723-z","volume":"22","author":"KM Maalej","year":"2023","unstructured":"Maalej KM, et al. CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. Mol Cancer. 2023;22(1):20.","journal-title":"Mol Cancer"},{"issue":"4","key":"2660_CR167","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ccell.2025.03.019","volume":"43","author":"B Du","year":"2025","unstructured":"Du B, et al. CAR-T therapy in solid tumors. Cancer Cell. 2025;43(4):665\u201379.","journal-title":"Cancer Cell"},{"key":"2660_CR168","doi-asserted-by":"publisher","first-page":"122475","DOI":"10.1016\/j.biomaterials.2024.122475","volume":"306","author":"J He","year":"2024","unstructured":"He J, et al. An injectable hydrogel microsphere-integrated training court to inspire tumor-infiltrating T lymphocyte potential. Biomaterials. 2024;306:122475.","journal-title":"Biomaterials"},{"issue":"5","key":"2660_CR169","doi-asserted-by":"publisher","first-page":"e2310078","DOI":"10.1002\/adma.202310078","volume":"36","author":"C Zhu","year":"2024","unstructured":"Zhu C, et al. Injectable Supramolecular Hydrogels for In Situ Programming of Car-T Cells toward Solid Tumor Immunotherapy. Adv Mater. 2024;36(5):e2310078.","journal-title":"Adv Mater"},{"issue":"16","key":"2660_CR170","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1021\/acs.accounts.4c00293","volume":"57","author":"P Liu","year":"2024","unstructured":"Liu P, Hu Q. Engineering Cells for Cancer Therapy. Acc Chem Res. 2024;57(16):2358\u201371.","journal-title":"Acc Chem Res"},{"issue":"21","key":"2660_CR171","doi-asserted-by":"publisher","first-page":"e2313188","DOI":"10.1002\/adma.202313188","volume":"36","author":"Y Peng","year":"2024","unstructured":"Peng Y, et al. Engineered Bio-Based Hydrogels for Cancer Immunotherapy. Adv Mater. 2024;36(21):e2313188.","journal-title":"Adv Mater"},{"issue":"43","key":"2660_CR172","doi-asserted-by":"publisher","first-page":"e2209778","DOI":"10.1002\/adma.202209778","volume":"36","author":"J Han","year":"2024","unstructured":"Han J, et al. Bioresponsive Immunotherapeutic Mater Adv Mater. 2024;36(43):e2209778.","journal-title":"Bioresponsive Immunotherapeutic Mater Adv Mater"},{"issue":"1","key":"2660_CR173","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41413-025-00471-8","volume":"13","author":"X Shi","year":"2025","unstructured":"Shi X, et al. Biomaterial-mediated macrophage polarization remodeling and sequential regulation: a potential strategy in bone infections treatment. Bone Res. 2025;13(1):96.","journal-title":"Bone Res"},{"issue":"40","key":"2660_CR174","doi-asserted-by":"publisher","first-page":"e13567","DOI":"10.1002\/advs.202513567","volume":"12","author":"Q Huang","year":"2025","unstructured":"Huang Q, et al. Tumor Microenvironment-Responsive Nanomedicines for Potentiating Cancer Immunotherapy. Adv Sci (Weinh). 2025;12(40):e13567.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2660_CR175","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12943-024-02032-9","volume":"23","author":"N Li","year":"2024","unstructured":"Li N, et al. A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapy. Mol Cancer. 2024;23(1):117.","journal-title":"Mol Cancer"},{"key":"2660_CR176","first-page":"206","volume":"37","author":"S Shang","year":"2024","unstructured":"Shang S, et al. Targeted therapy of kidney disease with nanoparticle drug delivery materials. Bioact Mater. 2024;37:206\u201321.","journal-title":"Bioact Mater"},{"issue":"11","key":"2660_CR177","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1007\/s00259-024-06743-5","volume":"51","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. [(18)F]AlF-NOTA-PCP2: a novel PET\/CT tracer for enhanced PD-L1 heterogeneity imaging and comparative analysis with [(18)F]AlF-NOTA-WL12 in glioblastoma xenografts. Eur J Nucl Med Mol Imaging. 2024;51(11):3161\u201375.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2660_CR178","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s13046-025-03567-5","volume":"44","author":"J Weng","year":"2025","unstructured":"Weng J, et al. Single-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers. J Exp Clin Cancer Res. 2025;44(1):314.","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"2660_CR179","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","volume":"19","author":"P Joyce","year":"2024","unstructured":"Joyce P, et al. A translational framework to DELIVER nanomedicines to the clinic. Nat Nanotechnol. 2024;19(11):1597\u2013611.","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"2660_CR180","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1021\/acsnano.4c12965","volume":"19","author":"YH Hwang","year":"2025","unstructured":"Hwang YH, et al. Robust, Scalable Microfluidic Manufacturing of RNA-Lipid Nanoparticles Using Immobilized Antifouling Lubricant Coating. ACS Nano. 2025;19(1):1090\u2013102.","journal-title":"ACS Nano"},{"issue":"Pt 2","key":"2660_CR181","doi-asserted-by":"publisher","first-page":"114370","DOI":"10.1016\/j.jconrel.2025.114370","volume":"388","author":"E Reus","year":"2025","unstructured":"Reus E, et al. Self-regulating microfluidic system for lipid nanoparticle production. J Control Release. 2025;388(Pt 2):114370.","journal-title":"J Control Release"},{"key":"2660_CR182","doi-asserted-by":"crossref","unstructured":"Mastella P, Luin S. Microfluidic Assembly of Poly(glutamic acid) Nanogels Through SPAAC Click Chemistry. Pharmaceutics, 2025; 17(9).","DOI":"10.3390\/pharmaceutics17091150"},{"issue":"11","key":"2660_CR183","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41570-025-00763-x","volume":"9","author":"T Kovacic","year":"2025","unstructured":"Kovacic T, et al. The impact of chemical reactivity on the quality and stability of RNA-LNP pharmaceuticals. Nat Rev Chem. 2025;9(11):790\u2013802.","journal-title":"Nat Rev Chem"},{"issue":"8","key":"2660_CR184","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1021\/acs.molpharmaceut.5c00056","volume":"22","author":"R Maheshwari","year":"2025","unstructured":"Maheshwari R, et al. Roadmap for Commercial Nanomedicine Development: Integrating Quality by Design Principles with Pharmaceutical Nanotechnology. Mol Pharm. 2025;22(8):4337\u201372.","journal-title":"Mol Pharm"},{"key":"2660_CR185","doi-asserted-by":"publisher","first-page":"107239","DOI":"10.1016\/j.ejps.2025.107239","volume":"213","author":"Y Ijjeh","year":"2025","unstructured":"Ijjeh Y, et al. Quality by digital design for accelerated sustainable nanomedicine development. Eur J Pharm Sci. 2025;213:107239.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"2660_CR186","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s13346-024-01681-z","volume":"15","author":"D Birla","year":"2025","unstructured":"Birla D, et al. Application of quality by design in optimization of nanoformulations: Principle, perspectives and practices. Drug Deliv Transl Res. 2025;15(3):798\u2013830.","journal-title":"Drug Deliv Transl Res"},{"issue":"3","key":"2660_CR187","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/CAD.0b013e328011a51d","volume":"18","author":"SJ Vukelja","year":"2007","unstructured":"Vukelja SJ, et al. Phase 1 study of escalating-dose OncoGel (ReGel\/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesions. Anticancer Drugs. 2007;18(3):283\u20139.","journal-title":"Anticancer Drugs"},{"issue":"2","key":"2660_CR188","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/CAD.0b013e3283222c12","volume":"20","author":"GA DuVall","year":"2009","unstructured":"DuVall GA, et al. Phase 2: a dose-escalation study of OncoGel (ReGel\/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancer. Anticancer Drugs. 2009;20(2):89\u201395.","journal-title":"Anticancer Drugs"},{"issue":"5","key":"2660_CR189","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ijrobp.2015.04.030","volume":"92","author":"N Mariados","year":"2015","unstructured":"Mariados N, et al. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015;92(5):971\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2660_CR190","doi-asserted-by":"publisher","first-page":"e1800275","DOI":"10.1002\/mabi.201800275","volume":"19","author":"H Lopez Hernandez","year":"2019","unstructured":"Lopez Hernandez H, et al. Non-Newtonian Polymer-Nanoparticle Hydrogels Enhance Cell Viability during Injection. Macromol Biosci. 2019;19(1):e1800275.","journal-title":"Macromol Biosci"},{"issue":"4","key":"2660_CR191","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.3171\/foc.2006.20.4.7","volume":"20","author":"R Raghavan","year":"2006","unstructured":"Raghavan R, et al. Convection-enhanced delivery of therapeutics for brain disease, and its optimization. Neurosurg Focus. 2006;20(4):E12.","journal-title":"Neurosurg Focus"},{"issue":"12","key":"2660_CR192","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1038\/s41417-022-00529-3","volume":"29","author":"S Pavuluri","year":"2022","unstructured":"Pavuluri S, Sheth RA. Overcoming biophysical barriers with innovative therapeutic delivery approaches. Cancer Gene Ther. 2022;29(12):1847\u201353.","journal-title":"Cancer Gene Ther"},{"key":"2660_CR193","doi-asserted-by":"publisher","first-page":"p110828","DOI":"10.1016\/j.compbiomed.2025.110828","volume":"196Pt B","author":"Z Liu","year":"2025","unstructured":"Liu Z, et al. Single-cell RNA sequencing reveals prolonged polyacrylamide hydrogel stimulation in vivo leads to an immunosuppressive microenvironment and potential tumorigenesis. Comput Biol Med. 2025;196Pt B:p110828.","journal-title":"Comput Biol Med"},{"issue":"3","key":"2660_CR194","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41556-023-01092-1","volume":"25","author":"B Wu","year":"2023","unstructured":"Wu B, et al. Stiff matrix induces exosome secretion to promote tumour growth. Nat Cell Biol. 2023;25(3):415\u201324.","journal-title":"Nat Cell Biol"},{"key":"2660_CR195","doi-asserted-by":"crossref","unstructured":"Wu L et al. Stiffness-Tunable Hydrogel Microfluidic Chip Reveals the Role of Stiffness in Cholangiocarcinoma Invasion and Pre-Metastatic Niche Formation. Adv Healthc Mater, 2025: e03515.","DOI":"10.1002\/adhm.202503515"},{"issue":"44","key":"2660_CR196","doi-asserted-by":"publisher","first-page":"30540","DOI":"10.1021\/acsnano.4c08922","volume":"18","author":"K Hulugalla","year":"2024","unstructured":"Hulugalla K, et al. Glycopolymeric Nanoparticles Enrich Less Immunogenic Protein Coronas, Reduce Mononuclear Phagocyte Clearance, and Improve Tumor Delivery Compared to PEGylated Nanoparticles. ACS Nano. 2024;18(44):30540\u201360.","journal-title":"ACS Nano"},{"key":"2660_CR197","doi-asserted-by":"publisher","first-page":"114447","DOI":"10.1016\/j.jconrel.2025.114447","volume":"389","author":"NU Kumari","year":"2026","unstructured":"Kumari NU, et al. Pre-programming the protein corona: From avoidance to endogenous targeting. J Control Release. 2026;389:114447.","journal-title":"J Control Release"},{"key":"2660_CR198","doi-asserted-by":"publisher","first-page":"114154","DOI":"10.1016\/j.jconrel.2025.114154","volume":"386","author":"Y Lu","year":"2025","unstructured":"Lu Y, et al. Customization of protein corona to reprogram cancer nanomedicines: Mechanistic insights and therapeutic implications. J Control Release. 2025;386:114154.","journal-title":"J Control Release"},{"issue":"20","key":"2660_CR199","doi-asserted-by":"publisher","first-page":"e2500043","DOI":"10.1002\/adma.202500043","volume":"37","author":"Z Jiang","year":"2025","unstructured":"Jiang Z, et al. AI-Guided Design of Antimicrobial Peptide Hydrogels for Precise Treatment of Drug-resistant Bacterial Infections. Adv Mater. 2025;37(20):e2500043.","journal-title":"Adv Mater"},{"issue":"17","key":"2660_CR200","doi-asserted-by":"publisher","first-page":"e2300816","DOI":"10.1002\/advs.202300816","volume":"10","author":"N Kim","year":"2023","unstructured":"Kim N, et al. 3D-Printed Functional Hydrogel by DNA-Induced Biomineralization for Accelerated Diabetic Wound Healing. Adv Sci (Weinh). 2023;10(17):e2300816.","journal-title":"Adv Sci (Weinh)"},{"key":"2660_CR201","doi-asserted-by":"publisher","first-page":"110252","DOI":"10.1016\/j.msec.2019.110252","volume":"106","author":"L Garcia-Del Rio","year":"2020","unstructured":"Garcia-Del Rio L, Diaz-Rodriguez P, Landin M. New tools to design smart thermosensitive hydrogels for protein rectal delivery in IBD. Mater Sci Eng C Mater Biol Appl. 2020;106:110252.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"1","key":"2660_CR202","doi-asserted-by":"publisher","first-page":"37408","DOI":"10.1038\/s41598-025-21282-1","volume":"15","author":"M Zhang","year":"2025","unstructured":"Zhang M, Wan Y, Li D. Predicted peptide scaffolds for drug screening in endometrial cancer organoids. Sci Rep. 2025;15(1):37408.","journal-title":"Sci Rep"},{"key":"2660_CR203","doi-asserted-by":"publisher","first-page":"101720","DOI":"10.1016\/j.apmt.2022.101720","volume":"30","author":"J Zhang","year":"2023","unstructured":"Zhang J, et al. Rapid, autonomous high-throughput characterization of hydrogel rheological properties via automated sensing and physics-guided machine learning. Appl Mater Today. 2023;30:101720.","journal-title":"Appl Mater Today"},{"issue":"1","key":"2660_CR204","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11164-019-03957-3","volume":"46","author":"C Boztepe","year":"2020","unstructured":"Boztepe C, et al. Prediction of the deswelling behaviors of pH- and temperature-responsive poly(NIPAAm-co-AAc) IPN hydrogel by artificial intelligence techniques. Res Chem Intermed. 2020;46(1):409\u201328.","journal-title":"Res Chem Intermed"},{"issue":"38","key":"2660_CR205","doi-asserted-by":"publisher","first-page":"2201843","DOI":"10.1002\/adfm.202201843","volume":"32","author":"B Chen","year":"2022","unstructured":"Chen B, et al. Artificial Intelligence-Assisted High-Throughput Screening of Printing Conditions of Hydrogel Architectures for Accelerated Diabetic Wound Healing. Adv Funct Mater. 2022;32(38):2201843.","journal-title":"Adv Funct Mater"},{"issue":"3","key":"2660_CR206","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1021\/acsbiomaterials.4c01636","volume":"11","author":"Y Chen","year":"2025","unstructured":"Chen Y, et al. Biofabrication of Tunable 3D Hydrogel for Investigating the Matrix Stiffness Impact on Breast Cancer Chemotherapy Resistance. ACS Biomater Sci Eng. 2025;11(3):1417\u201331.","journal-title":"ACS Biomater Sci Eng"},{"issue":"8","key":"2660_CR207","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1021\/acsbiomaterials.5c00705","volume":"11","author":"T Tao","year":"2025","unstructured":"Tao T, et al. A Synthetic Hydrogel with Tunable Stiffness for Engineering Pancreatic Cancer Organoids and Drug Testing. ACS Biomater Sci Eng. 2025;11(8):5000\u201311.","journal-title":"ACS Biomater Sci Eng"},{"issue":"31","key":"2660_CR208","doi-asserted-by":"publisher","first-page":"eadt1851","DOI":"10.1126\/sciadv.adt1851","volume":"11","author":"I Yakavets","year":"2025","unstructured":"Yakavets I, et al. Machine learning-assisted exploration of multidrug-drug administration regimens for organoid arrays. Sci Adv. 2025;11(31):eadt1851.","journal-title":"Sci Adv"},{"issue":"9","key":"2660_CR209","doi-asserted-by":"publisher","first-page":"e2300553","DOI":"10.1002\/smtd.202300553","volume":"7","author":"M Seifermann","year":"2023","unstructured":"Seifermann M, et al. High-Throughput Synthesis and Machine Learning Assisted Design of Photodegradable Hydrogels. Small Methods. 2023;7(9):e2300553.","journal-title":"Small Methods"},{"key":"2660_CR210","doi-asserted-by":"publisher","first-page":"101014","DOI":"10.1016\/j.mtbio.2024.101014","volume":"25","author":"Z Li","year":"2024","unstructured":"Li Z, et al. AI energized hydrogel design, optimization and application in biomedicine. Mater Today Bio. 2024;25:101014.","journal-title":"Mater Today Bio"},{"issue":"1","key":"2660_CR211","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1039\/D5BM01191D","volume":"14","author":"P Yin","year":"2026","unstructured":"Yin P, et al. Core-shell hydrogel microspheres with sequential drug release and magnetothermal synergy for drug-resistant ovarian cancer. Biomater Sci. 2026;14(1):161\u201372.","journal-title":"Biomater Sci"},{"key":"2660_CR212","first-page":"144","volume":"55","author":"C Zhang","year":"2026","unstructured":"Zhang C, et al. Dynamic hydrogel mechanics in organoid engineering: From matrix design to translational paradigms. Bioact Mater. 2026;55:144\u201370.","journal-title":"Bioact Mater"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02660-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02660-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02660-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:28:04Z","timestamp":1779424084000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02660-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":212,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2660"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02660-3","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final version of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}